Login Register
icon_bulk_orderBulk order Acrobiosystems for English
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CAR-T > HLA-A*02:01 & B2M & Glycipan 3 > HLG-H52E5

Human HLA-A*02:01&B2M&Glycipan 3 (FVGEFFTDV) Tetramer Protein (MALS verified)

  • Synonym
    HLA-A*02:01 & B2M & Glycipan 3
  • Source
    Human HLA-A*02:01&B2M&Glycipan 3 (FVGEFFTDV) Tetramer Protein(HLG-H52E5) is expressed from human 293 cells (HEK293). It contains AA Gly 25 - Thr 305 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & FVGEFFTDV peptide (Accession # A0A140T913 (HLA-A*02:01) & P61769 (B2M) & FVGEFFTDV ).
    Predicted N-terminus: Gly 25 & Phe
  • Molecular Characterization

    Human HLA-A*02:01&B2M&Glycipan 3 (FVGEFFTDV) Tetramer Protein is assembled by biotinylated monomer (HLG-H82E4) and streptavidin.

    Biotinylated Human HLA-A*02:01&B2M&Glycipan 3 (FVGEFFTDV) Complex Protein is produced by co-expression of HLA and B2M loaded with Glycipan 3 peptide. Biotinylated Human HLA-A*02:01&B2M&Glycipan 3 (FVGEFFTDV) Complex Protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 36.0 kDa and 13.8 kDa. The protein migrates as 42-45 kDa, 15 kDa and 14 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
HLA-A*02:01 & B2M & Glycipan 3 SDS-PAGE

Human HLA-A*02:01&B2M&Glycipan 3 (FVGEFFTDV) Tetramer Protein on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.

HLA-A*02:01 & B2M & Glycipan 3 MALS images

The purity of Human HLA-A*02:01&B2M&Glycipan 3 (FVGEFFTDV) Tetramer Protein (Cat. No. HLG-H52E5) is more than 90% and the molecular weight of this protein is around 240-270 kDa verified by SEC-MALS.

  • Background
    Glypican-3 (GPC3) is also known as Intestinal protein OCI-5, GTR2-2, MXR7, which belongs to the glypican family. Glypican 3 / GPC-3 is highly expressed in lung, liver and kidney. Glypican-3 inhibits the dipeptidyl peptidase activity of DPP4. Glypican-3 may be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs, and also may play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. The Human HLA-A*0201 Glycipan 3 (FVGEFFTDV) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M and FVGEFFTDV peptide of the Glycipan 3 .
  • Clinical and Translational Updates
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

Comments (0)

ETD of in-stock products: 2 business days

Price(USD) : $280.00

Price(USD) : $1600.00

Promotion & Exhibitions

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message